An anti-obesity drug vastly outperforms currently available rivals, early trials suggest.
Danish tests of tesofensine, reported in The Lancet, found dieting patients on the highest doses lost up to 12.8kg (28.2lbs) in six months.
This is twice the level achieved by drugs such as sibutramine and rimonabant.
But UK experts warned that more trials were needed, and expressed concerned the results may have been hyped.
Tesofensine first came to the attention of obesity researchers when it caused unintended weight loss when given to overweight patients with Parkinson's or Alzheimer's disease.
It works by changing the way that three nerve signalling chemicals, noradrenaline, dopamine, and serotonin have their effects on the brain.
This in turn reduces appetite, so that the person will eat smaller meals and have a reduced urge to snack. - BBC News
Linkback:
https://tubagbohol.mikeligalig.com/index.php?topic=15915.0
